These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24448890)

  • 1. Concise review: a population shift view of cellular reprogramming.
    Del Sol A; Buckley NJ
    Stem Cells; 2014 Jun; 32(6):1367-72. PubMed ID: 24448890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concise review: Induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart?
    Bilic J; Izpisua Belmonte JC
    Stem Cells; 2012 Jan; 30(1):33-41. PubMed ID: 22213481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single cell analysis reveals the stochastic phase of reprogramming to pluripotency is an ordered probabilistic process.
    Chung KM; Kolling FW; Gajdosik MD; Burger S; Russell AC; Nelson CE
    PLoS One; 2014; 9(4):e95304. PubMed ID: 24743916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward pluripotency by reprogramming: mechanisms and application.
    Wang T; Warren ST; Jin P
    Protein Cell; 2013 Nov; 4(11):820-32. PubMed ID: 24078387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming cancer cells: a novel approach for cancer therapy or a tool for disease-modeling?
    Yilmazer A; de Lázaro I; Taheri H
    Cancer Lett; 2015 Dec; 369(1):1-8. PubMed ID: 26276716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can controlled cellular reprogramming be achieved using microRNAs?
    Sun X; Fu X; Han W; Zhao Y; Liu H
    Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concise review: harmonies played by microRNAs in cell fate reprogramming.
    Moradi S; Asgari S; Baharvand H
    Stem Cells; 2014 Jan; 32(1):3-15. PubMed ID: 24155164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural and artificial routes to pluripotency.
    Krueger WH; Swanson LC; Tanasijevic B; Rasmussen TP
    Int J Dev Biol; 2010; 54(11-12):1545-64. PubMed ID: 21404178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular reprogramming by transcription factor engineering.
    Tsang JC; Gao X; Lu L; Liu P
    Curr Opin Genet Dev; 2014 Oct; 28():1-9. PubMed ID: 25151337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased reprogramming capacity of mouse liver progenitor cells, compared with differentiated liver cells, requires the BAF complex.
    Kleger A; Mahaddalkar PU; Katz SF; Lechel A; Joo JY; Loya K; Lin Q; Hartmann D; Liebau S; Kraus JM; Cantz T; Kestler HA; Zaehres H; Schöler H; Rudolph KL
    Gastroenterology; 2012 Apr; 142(4):907-17. PubMed ID: 22245845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NuRD blocks reprogramming of mouse somatic cells into pluripotent stem cells.
    Luo M; Ling T; Xie W; Sun H; Zhou Y; Zhu Q; Shen M; Zong L; Lyu G; Zhao Y; Ye T; Gu J; Tao W; Lu Z; Grummt I
    Stem Cells; 2013 Jul; 31(7):1278-86. PubMed ID: 23533168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic dedifferentiation of somatic cells into pluripotency: cellular alchemy in the age of regenerative medicine?
    Oliveri RS
    Regen Med; 2007 Sep; 2(5):795-816. PubMed ID: 17907932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise review: non-cell autonomous reprogramming: a nucleic acid-free approach to induction of pluripotency.
    Parameswaran S; Balasubramanian S; Rao MS; Ahmad I
    Stem Cells; 2011 Jul; 29(7):1013-20. PubMed ID: 21544901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprogramming somatic cells into pluripotent stem cells using miRNAs.
    Anokye-Danso F
    Methods Mol Biol; 2014; 1150():273-81. PubMed ID: 24744006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of genomic imprinting by reprogramming and redifferentiation.
    Kim MJ; Choi HW; Jang HJ; Chung HM; Arauzo-Bravo MJ; Schöler HR; Do JT
    J Cell Sci; 2013 Jun; 126(Pt 11):2516-24. PubMed ID: 23525019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular barriers to processes of genetic reprogramming and cell transformation.
    Chestkov IV; Khomyakova EA; Vasilieva EA; Lagarkova MA; Kiselev SL
    Biochemistry (Mosc); 2014 Dec; 79(12):1297-307. PubMed ID: 25716723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states.
    Hotta A; Ellis J
    J Cell Biochem; 2008 Nov; 105(4):940-8. PubMed ID: 18773452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A medium-throughput analysis of signaling pathways involved in early stages of stem cell reprogramming.
    Fritz AL; Mao SR; West MG; Schaffer DV
    Biotechnol Bioeng; 2015 Jan; 112(1):209-19. PubMed ID: 25065366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concise review: the dynamics of induced pluripotency and its behavior captured in gene network motifs.
    Muraro MJ; Kempe H; Verschure PJ
    Stem Cells; 2013 May; 31(5):838-48. PubMed ID: 23362218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.